ReviewCancers2022
Updates in the Role of Checkpoint Inhibitor Immunotherapy in Classical Hodgkin's Lymphoma.
Shazia Nakhoda et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this paperpooled itcites it
ReviewCancers2022
Shazia Nakhoda et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.